What is next for pharmacoeconomics and outcomes research in Asia?

  title={What is next for pharmacoeconomics and outcomes research in Asia?},
  author={Jim P Doherty and Isao Kamae and Kenneth Kwing-Chin Lee and Hong Li and Shu-Chun Li and G Liu and Y H Tarn and Bong-min Yang},
  journal={Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
  volume={7 2},
OBJECTIVES Pharmacoeconomics and outcomes research have the potential for rapid adoption in the Asia Pacific region. Nevertheless, the region is characterized by great diversity in social and economic development, ethnicity, population size, health-care system, culture, language, and religion. Thus, the rate of adoption is also quite diverse across the region. METHODS Among the countries reviewed in this article, governments take varying levels of interest in applying this research in health… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 23 extracted citations


Publications referenced by this paper.
Showing 1-10 of 39 references

Pharmacoeconomics 2003;21:913–25

  • H Sakamaki, N Hiromori, Y Aburaya, Nakamura
  • 2003

Validation of the medical outcomes short - form 36 survey ( SF - 36 ) for quality - of - life assessment of chinese patients with anxiety disorders in Singapore

  • N Luo, S Leng, C Fongs, SC Li
  • Qual Life Res
  • 2003

studies in Japan

  • H Sakamaki, N Hiromori, Y Aburaya, K Nakamura
  • 2003

A survey of public hospital pharmacists in Singapore on their views about the formulary and its decision - making process

  • AN Roy, SC Li
  • Value Health
  • 2002

Demand for health care in urban China

  • R. Fogel
  • Contemp Econ Policy
  • 2002

Evidence - based medicine , pharmacoeconomics , and appropriate drug use

  • MZ Liu
  • 2002

Evidence-based medicine, pharmacoeconomics, and appropriate drug use. China Pharmacy 2002;13:342–8

  • MZ Liu
  • 2002

Similar Papers

Loading similar papers…